Meta Platforms
META
Ecopetrol
EC
MARA Holdings
MARA
Oracle
ORCL
Salesforce
CRM
US Stock MarketDetailed Quotes
CNTA Centessa Pharmaceuticals
- 16.280
- -0.400-2.40%
Close Jan 23 16:00 ET
- 16.280
- 0.0000.00%
Post 16:49 ET
2.15BMarket Cap-10.71P/E (TTM)
16.920High16.280Low436.37KVolume16.620Open16.680Pre Close7.23MTurnover0.48%Turnover RatioLossP/E (Static)131.85MShares18.97052wk High4.30P/B1.47BFloat Cap7.38052wk Low--Dividend TTM90.23MShs Float26.900Historical High--Div YieldTTM3.84%Amplitude2.885Historical Low16.564Avg Price1Lot Size
About Centessa Pharmaceuticals Company
Centessa Pharmaceuticals Plc operates as clinical-stage pharmaceutical company, which engages in discovering and developing medicines that delivers transformational to patients. Its portfolio include preclinical to phase three uncorrelated programs spanning diseases with high unmet need across oncology, hematology, immunology, inflammation, neuroscience, and rare diseases. The company was founded on October 26, 2020 and is headquartered in Altrincham, the United Kingdom.
Company Profile
SymbolCNTA
Company NameCentessa Pharmaceuticals
Listing DateMay 28, 2021
Issue Price20.00
Founded2020
CEODr. Saurabh Saha, M.D.,PhD
MarketNASDAQ
Employees153
Securities TypeDR
ADS Ratio1.0 : 1.0
Fiscal Year Ends12-31
Address1 Ashley Road,3rd Floor
CityAltrincham
ProvinceCambridgeshire
CountryUnited Kingdom of Great Britain and Northern Ireland (the)
Zip CodeWA14 2DT
Phone44-7391-789784
Websitehttp://centessa.com
Company Executives
- Name
- Position
- Salary
- Dr. Saurabh Saha, M.D.,PhD
- Chief Executive Officer and Director
- 2.71M
- Dr. Gregory M. Weinhoff, M.B.A.,M.D.
- Chief Business Officer
- --
- Iqbal Hussain
- General Counsel, Chief Compliance Officer and Company Secretary
- --
- John Crowley
- Chief Financial Officer and Principal Accounting Officer
- --
- Tia Bush
- Chief Quality Officer and Chief Technology Officer
- --
- Karen Anderson
- Chief People Officer
- --
- Dr. David Chao, PhD
- Chief Administrative Officer
- 1.32M
- Dr. Francesco De Rubertis, PhD
- Chairman of the Board
- --
- Carol Stuckley, M.B.A.
- Independent Director
- 262.69K
- Dr. Mathias Hukkelhoven, PhD
- Independent Director
- 247.69K
- Dr. Arjun Goyal, M.B.A.,M.D.,M.Phil
- Independent Director
- 260.19K
- Dr. Samarth Kulkarni, PhD
- Independent Director
- 255.19K
- Dr. Mary Lynne Hedley,PhD
- Independent Director
- 255.19K
- Dr. Brett Zbar, M.D.
- Independent Director
- 257.69K
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.